Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy

Ophthalmology

Volumn 106, Issue 9, 1999, Pages 1756-1761

  Salomão, Diva R ^a,b   Mathers, William D ^a   Sutphin, John E ^a   Cuevas, Kevin ^a   Folberg, Robert ^a,c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CHROMATIN; CHRONIC INFLAMMATION; CONJUNCTIVA EPITHELIUM; CYTOLOGY; FEMALE; HUMAN; MALE; MELANOSIS; PRIORITY JOURNAL; TUMOR RECURRENCE;

EID: 0033506184     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90355-X     Document Type: Article

References (21)

1. Badalament RA, Farah RN. Treatment of superficial bladder cancer with intravesical chemotherapy. Semin Surg Oncol 1997;13:335-41.
2. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology 1992;99:1471-6.
3. Frucht-Pery J, Siganos CS, Ilsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 1996;103:674-7.
4. Secchi AG, Tognon MS. Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices. Am J Ophthalmol 1996;122:728-30.
5. Frucht-Pery J, Pe'er J. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 1996;114:1261-4.
6. Heigle TJ, Stulting RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 1997;124:397-9.
7. Tseng SH, Tsai YY, Chen FK. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C. Cornea 1997;16:595-7.
8. Murphy WM, Soloway MS, Finebaum PJ. Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 1981;126:461-4.
9. Koshikawa T, Leyh H, Schenck U. Difficulties in evaluating urinary specimens after local mitomycin therapy of bladder cancer. Diagn Cytopathol 1989;5:117-21.
10. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985;16:129-35.
11. Koss LG, Melamed MR, Mayer K. The effect of Busulfan on human epithelia. Am J Clin Pathol 1965;44:385-97.
12. Hamdy FC, Hastie KJ, Kerry R, Williams JL. Mitomycin-C in superficial bladder cancer. Is long-term maintenance therapy worthwhile after initial treatment? Br J Urol 1993; 71:183-6.
13. Soloway MS, Murphy WM, De Furia MD, et al. The effect of mitomycin C on superficial bladder cancer. J Urol 1981;125: 646-8
14. Calabresi P, Parks RE. Antiproliferative agents and drugs used for immunosuppression. In: Gilman AG (ed). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edition. New York: Pergamon Press. 1990; 1247-8.
15. Murphy WM, Soloway MS, Crabtree WN. The morphologic effects of mitomycin C in mammalian urinary bladder. Cancer 1981;47:2567-74.
16. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991;98:317-21.
17. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95:813-21.
18. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 1994;117:164-8.
19. Wilson MW, Hungerford JL, George SM, Madreperla SA. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 1997;124:303-11.
20. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia. A multicenter experience. Ophthalmology 1997;104:2085-93.
21. Grossniklaus HE, Aaberg TM Sr. Mitomycin C treatment of conjunctival intraepithelial neoplasia [editorial]. Am J Ophthalmol 1997;124:381-3.